Parnell Pharmaceuticals Holdings Number of Employees 2014-2018 | PARNF
Parnell Pharmaceuticals Holdings number of employees from 2014 to 2018. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Parnell Pharmaceuticals Holdings Annual Employee Count |
| 2021 |
N/A |
| 2020 |
N/A |
| 2019 |
N/A |
| 2018 |
N/A |
| 2017 |
N/A |
| 2016 |
78 |
| 2015 |
126 |
| 2014 |
N/A |
| 2014 |
51 |
| 2013 |
N/A |
| 2013 |
55 |
| 2012 |
N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
